Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin’s Lymphoma Cell Death

Telomere maintenance is key during cancer development. Malignant cells can either use telomerase or an alternative lengthening of telomere (ALT) pathway to maintain their telomere length. In Hodgkin’s Lymphoma (HL), the presence of telomerase activation is established. The activation of ALT has been...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lima, Matheus Fabiao, Freitas, Monique Oliveira, Hamedani, Mohammad K., Rangel-Pozzo, Aline, Zhu, Xu-Dong, Mai, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496562/
https://www.ncbi.nlm.nih.gov/pubmed/36140400
http://dx.doi.org/10.3390/biomedicines10092299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496562/
https://www.ncbi.nlm.nih.gov/pubmed/36140400
http://dx.doi.org/10.3390/biomedicines10092299

Ejemplares similares